Posted in | News | Business

Siemens to License Advanced Gas Turbine Technology

Siemens Energy and the Russian power plant supplier Power Machines are to further expand their cooperation. The two companies signed an agreement in St. Petersburg on the licensing of Siemens advanced gas turbine technology. Under the terms of the licensing agreement Power Machines will acquire from Siemens the technology and production, marketing and service rights for SGT5-4000F gas turbines rated at 285 megawatts (MW).

At the same time Siemens signed a shareholder’s agreement with Alexey Mordashov, the principal stakeholder in Power Machines, covering the modalities of the cooperation for further development and modernization of Power Machines. “Since Alexey Mordashov, the new principal shareholder, came on board, the dynamics of cooperation with Power Machines have significantly increased. Together with our partner Power Machines we have already secured orders in Russia for a large number of power plant projects,” said Peter Löscher, CEO of Siemens AG.

Power Machines will produce SGT5-4000F gas turbines and market them for power plant projects in Russia, Belarus, the CIS, the Baltic States and India. Production of the components for the first gas turbine of this type in Russia is scheduled to begin in 2009. Power Machines will handle machine assembly.

“Siemens is not only providing the technology; we are also supporting Power Machines with state-of-the-art management know-how and providing the company’s COO,” said Löscher. With an installed capacity of 218 gigawatts Russia is the world’s fourth largest power market. The country’s power supply situation is facing a major challenge: The task in hand is to replace and expand the aging power plant fleet. High-efficiency combined cycle power plants will be of major importance for power generation in Russia in the future. Only in July last year Siemens had awarded its partner Power Machines a license for a gas turbine with a rating of 165 MW.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.